128 related articles for article (PubMed ID: 6419377)
1. Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates.
Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Taube C; Förster V
Thromb Res; 1983 Nov; 32(3):255-66. PubMed ID: 6419377
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
Mazurov AV; Leĭtin VL; Repin VS
Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid and stable analogue of prostaglandin endoperoxides (U46619) induce platelet spreading and thrombi-like aggregate formation on a collagen substrate. Effect of fluid dynamics.
Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Förster W
Thromb Res; 1983 Oct; 32(2):189-205. PubMed ID: 6419375
[TBL] [Abstract][Full Text] [Related]
4. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
5. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
[TBL] [Abstract][Full Text] [Related]
6. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
7. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
8. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytosolic Ca++ mobilization in human platelets by the antianginal drug trapidil and its derivative AR 12463.
Block HU; Gabbasov ZA; Pozin EY; Popov EG; Mest HJ
Biomed Biochim Acta; 1988; 47(12):1093-7. PubMed ID: 2855396
[TBL] [Abstract][Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thromboxane A2 production by trapidil and trapidil derivatives in the arachidonic acid-injected rat.
Heinroth-Hoffmann I; Hauser A; Mest HJ
Prostaglandins Leukot Med; 1987 Dec; 30(2-3):87-92. PubMed ID: 2827194
[TBL] [Abstract][Full Text] [Related]
12. Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets.
Block HU; Dunemann A; Niebisch M; Mest HJ
Biomed Biochim Acta; 1988; 47(10-11):S141-4. PubMed ID: 3248101
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
14. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
Vargaftig B; Joseph D; Hatmi M
Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester stimulates platelet spreading and thrombi-like aggregate formation on the surface of immobilized type V collagen.
Leytin VL; Misselwitz F; Avdonin PV; Podrez FA; Domogatsky SP; Tkachuk VA
Thromb Res; 1989 Aug; 55(3):309-18. PubMed ID: 2781531
[TBL] [Abstract][Full Text] [Related]
16. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
17. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
Hanasaki K; Nakano T; Arita H
Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
[TBL] [Abstract][Full Text] [Related]
18. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
Nakano T; Hanasaki K; Arita H
J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
